How big data can help Prostate Cancer patients
Read morePress Release: How big data can help Prostate Cancer patients Innovative Medicines Initiative approves € 12 million public-private research project for improved care of prostate cancer patients. The Innovative Medicines Initiative (IMI) has approved PIONEER, a brand new five-year...
Contact us here
PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. IMI2 receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
